OxyMem
Athlone
About OxyMem
OxyMem solves energy intensive wastewater treatment with an innovative ‘Drop in’ solution for wastewater aeration, the Membrane Aerated Biofilm Reactor (MABR). OxyMem MABR complements existing treatment systems and delivers up to 50% additional biological capacity in an existing aeration or alternatively enables you to replace a legacy system. Conventional wastewater treatment consumes 2-3% of a nation’s electricity production. This is due a 100 years reliance on bubble diffusion for conventional treatment plants which will typically suffer energy losses of 65-70% in the process because of the oxygen transfer limitations in the process. OxyMem does not have any such limitations. OxyMem uses hollow fibre gas permeable membranes to support a fixed film ecosystem for the biology which allows for direct delivery of oxygen to the micro-organisms. OxyMem can achieve 95% oxygen transfer rates which results in superior energy performance (75% saving), lower sludge production (50% less sludge), along with impressive process resilience.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Funding stage: M&A
- Last round: Series Unknown (Jun 2017)
- Website: oxymem.com
- Phone: +353906465727
Industries & Categories
Biotechnology, Energy, Environmental Engineering, Waste Management, Water
Social Profiles
Canonical: https://fsome.com/organization/oxymem-2452455 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.